Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers

PF Bonventre, C Linnemann… - Journal of Infectious …, 1984 - academic.oup.com
PF Bonventre, C Linnemann, LS Weckbach, JL Staneck, C Ralph Buncher, E Vigdorth…
Journal of Infectious Diseases, 1984academic.oup.com
Serum samples taken from women with toxic-shock syndrome (TSS) and from women
without a history of TSS were examined for the presence of antibodies to toxic-shock-
syndrome toxin (TST). Serum samples from 38 women with TSS and from 70 women with no
history of TSS were analyzed by radioimmunoassay (RIA) and by an enzyme-linked
immunoadsorbent assay (ELISA). Antitoxin titers obtained by the assays were highly
correlated. Antibody levels in sera of women with TSS, or a history of TSS, were significantly …
Abstract
Serum samples taken from women with toxic-shock syndrome (TSS) and from women without a history of TSS were examined for the presence of antibodies to toxic-shock-syndrome toxin (TST). Serum samples from 38 women with TSS and from 70 women with no history of TSS were analyzed by radioimmunoassay (RIA) and by an enzyme-linked immunoadsorbent assay (ELISA). Antitoxin titers obtained by the assays were highly correlated. Antibody levels in sera of women with TSS, or a history of TSS, were significantly lower than levels in sera of women with no prior evidence of TSS. The mean level of antitoxin titers in the total sample of acute, convalescent, and recovered TSS groups was significantly lower than that of the control groups, which consisted of 31 carriers of genital Staphylococcus aureus and a similar number of age- and racematched noncarriers. Although a trend toward elevated antitoxin titers was apparent after recovery, no vigorous immunologic response to TST was noted. In contrast, the majority of healthy women demonstrated measurable antitoxin titers, a finding indicative of current or prior colonization with TST-producing strains of S. aureus. The data suggest that absence of antibodies to the TSS toxin may be a predisposing factor in the development of clinical disease.
Oxford University Press